Slideshow: Where the Biotech & Device Investors Are–Q4 Edition

Lately, there’s been a whole lot of bemoaning of this and that to explain why VCs are abandoning the biotech and device space and why strategics are slowing early-stage funding. Lawmakers and regulators have made it too tough to IPO. Lawmakers and regulators have made it too tough to get anything approved at the FDA. […]

Biocartis Adds $100M Equity Financing

Swiss biotech start-up Biocartis has raised 71 million euro ($100 million) in Series C financing. Investors in the round include Debiopharm Group, Philips, Johnson & Johnson Development Corp., the Wellcome Trust, Korys, Valiance and Biovest. The money will be used to help commercialize the company’s compact molecular diagnostics system.

PEHUB Community

Join the 12493 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget